Cargando…

A Multi-Institutional Retrospective Analysis of Toceranib Phosphate for Presumed or Confirmed Canine Aortic Body Chemodectomas

Aortic body tumors, specifically chemodectomas, are the second most common type of canine cardiac tumor; however, information about treatment is currently lacking. This study included dogs with a presumptive or definitive diagnosis of an aortic body chemodectoma that underwent treatment with toceran...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coto, Giovanna M., Musser, Margaret L., Tropf, Melissa A., Ward, Jessica L., Seo, Yeon-Jung, Mochel, Jonathan P., Johannes, Chad M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Veterinary Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892462/ https://www.ncbi.nlm.nih.gov/pubmed/33614771 http://dx.doi.org/10.3389/fvets.2021.635057

Ejemplares similares

Toceranib phosphate (Palladia) for the treatment of canine exocrine pancreatic adenocarcinoma
por: Musser, Margaret L., et al.
Publicado: (2021)

Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of gastrointestinal stromal tumors of dogs
por: Berger, Erika P., et al.
Publicado: (2018)

Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of inoperable, metastatic, or recurrent canine pheochromocytomas: 5 dogs (2014–2017)
por: Musser, Margaret L., et al.
Publicado: (2018)

Transcriptome of Two Canine Prostate Cancer Cells Treated With Toceranib Phosphate Reveals Distinct Antitumor Profiles Associated With the PDGFR Pathway
por: Kobayashi, Priscila E., et al.
Publicado: (2020)

Case report: Malignant chemodectoma with hepatic metastasis in a cat
por: Adetunji, Shakirat Adeola, et al.
Publicado: (2023)

Transvalvular Pulmonary Stent Angioplasty for Management of an Intraluminal, Compressive Chemodectoma in a Dog
por: Winter, Randolph L., et al.
Publicado: (2023)

Caval chemodectoma in a cat
por: Martinez, Irene, et al.
Publicado: (2022)

Development of an in vitro model of acquired resistance to toceranib phosphate (Palladia®) in canine mast cell tumor
por: Halsey, Charles HC, et al.
Publicado: (2014)

Toceranib phosphate in the management of canine insulinoma: A retrospective multicentre study of 30 cases (2009–2019)
por: Sheppard‐Olivares, Sabina, et al.
Publicado: (2022)

Pilot safety evaluation of doxorubicin chemotherapy combined with non-specific immunotherapy (Immunocidin®) for canine splenic hemangiosarcoma
por: Musser, Margaret L., et al.
Publicado: (2022)

Effects of Toceranib Phosphate on Systolic Blood Pressure and Proteinuria in Dogs
por: Tjostheim, S.S., et al.
Publicado: (2016)

Characterization of receptor tyrosine kinase activation and biological activity of toceranib phosphate in canine urothelial carcinoma cell lines
por: Korec, Daniela I., et al.
Publicado: (2021)

Case report: Toceranib as adjuvant chemotherapy in a dog with incompletely resected combined hepatocellular-cholangiocarcinoma
por: Kim, Sang-Won, et al.
Publicado: (2023)

Ultrasound-Guided Radiofrequency Ablation of Chemodectomas in Five Dogs
por: Gómez Ochoa, Pablo, et al.
Publicado: (2021)

Toceranib phosphate-associated nephrotic syndrome in a dog: a case report
por: Remerowski, Shannon M., et al.
Publicado: (2021)

Effects of Toceranib Phosphate on the Hypothalamic‐Pituitary‐Thyroid Axis in Tumor‐Bearing Dogs
por: Hume, K.R., et al.
Publicado: (2017)

A pilot study of toceranib/vinblastine therapy for canine transitional cell carcinoma
por: Rippy, Sarah B., et al.
Publicado: (2016)

Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma
por: Gardner, Heather L., et al.
Publicado: (2015)

Effects of toceranib phosphate (Palladia) monotherapy on multidrug resistant lymphoma in dogs
por: YAMAZAKI, Hiroki, et al.
Publicado: (2017)

Case report: Adjuvant therapy with toceranib for an incompletely resected renal cell carcinoma with suspected pulmonary metastasis in a dog
por: Lee, Da-Eun, et al.
Publicado: (2023)

Erratum to: A pilot study of toceranib/vinblastine therapy for canine transitional cell carcinoma
por: Rippy, Sarah B., et al.
Publicado: (2016)

Assessment of postoperative adjuvant treatment using toceranib phosphate against adenocarcinoma in dogs
por: Yamazaki, Hiroki, et al.
Publicado: (2020)

Toceranib phosphate and firocoxib-mediated partial response in a dog with advanced intranasal sarcoma
por: OSADA, Hironari, et al.
Publicado: (2023)

Toceranib phosphate (Palladia) reverses type 1 diabetes by preserving islet function in mice
por: KISHI, Kazuhisa, et al.
Publicado: (2023)

Pulse‐Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs
por: Burton, J.H., et al.
Publicado: (2015)

Long-term survival in a cat with pancreatic adenocarcinoma treated with surgical resection and toceranib phosphate
por: Todd, Johanna E, et al.
Publicado: (2020)

Long-term survival in a dog with primary hepatic neuroendocrine tumor treated with toceranib phosphate
por: ICHIMATA, Masanao, et al.
Publicado: (2021)

Combination vinblastine, prednisolone and toceranib phosphate for treatment of grade II and III mast cell tumours in dogs
por: Olsen, Jaime A., et al.
Publicado: (2018)

In vitro Cytotoxicity and Pharmacokinetic Evaluation of Pharmacological Ascorbate in Dogs
por: Musser, Margaret L., et al.
Publicado: (2019)

Presumed Primary Bacterial Rhinosinusitis-Associated Optic Neuritis in a Cat
por: Moghaddam, Rachael, et al.
Publicado: (2020)

Osteogenic differentiation of adipose-derived canine mesenchymal stem cells seeded in porous calcium-phosphate scaffolds
por: Herrera, David, et al.
Publicado: (2023)

Culture and characterization of canine and feline corneal epithelial organoids: A new tool for the study and treatment of corneal diseases
por: Bedos, Leila, et al.
Publicado: (2022)

Confirmation of canine acanthomatous ameloblastoma using RAS Q61R immunohistochemical staining of formalin-fixed paraffin-embedded tissues
por: Peralta, Santiago, et al.
Publicado: (2023)

Losartan Blocks Osteosarcoma-Elicited Monocyte Recruitment, and Combined With the Kinase Inhibitor Toceranib, Exerts Significant Clinical Benefit in Canine Metastatic Osteosarcoma
por: Regan, Daniel P., et al.
Publicado: (2022)

Transient Postural Vestibulo-Cerebellar Syndrome in Three Dogs With Presumed Cerebellar Hypoplasia
por: Prikryl, Miroslav, et al.
Publicado: (2020)

Evaluation of the adverse event profile and pharmacodynamics of toceranib phosphate administered to dogs with solid tumors at doses below the maximum tolerated dose
por: Bernabe, Luis Feo, et al.
Publicado: (2013)

Feline restrictive orbital myofibroblastic sarcoma treated with toceranib phosphate (Palladia) as adjuvant chemotherapy: A case study of one cat
por: Komatsu, Hiroyuki, et al.
Publicado: (2023)

Low-Field Magnetic Resonance Imaging Findings in 18 Dogs With Presumed Optic Neuritis
por: Muñiz Moris, Laura, et al.
Publicado: (2021)

Commentary: Transient Postural Vestibulo-Cerebellar Syndrome in Three Dogs With Presumed Cerebellar Hypoplasia
por: Tamura, Shinji
Publicado: (2021)

Corrigendum: Transient Postural Vestibulo-Cerebellar Syndrome in Three Dogs With Presumed Cerebellar Hypoplasia
por: Prikryl, Miroslav, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_upu7i4u9joavr698drcf6q0u0u